Crescent Grove Advisors LLC Has $9.61 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Crescent Grove Advisors LLC decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 97,218 shares of the exchange traded fund’s stock after selling 6,285 shares during the quarter. SPDR S&P Biotech ETF accounts for about 1.0% of Crescent Grove Advisors LLC’s investment portfolio, making the stock its 23rd biggest holding. Crescent Grove Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $9,605,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after purchasing an additional 730,000 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in SPDR S&P Biotech ETF by 1.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after purchasing an additional 18,202 shares during the last quarter. Jane Street Group LLC lifted its holdings in SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares during the last quarter. Bessemer Group Inc. raised its position in shares of SPDR S&P Biotech ETF by 1.7% in the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after purchasing an additional 15,794 shares during the period. Finally, Employees Retirement System of Texas boosted its holdings in shares of SPDR S&P Biotech ETF by 40.8% during the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after buying an additional 174,857 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $100.62 on Wednesday. The stock’s 50-day moving average is $98.83 and its 200-day moving average is $95.15. The company has a market cap of $7.67 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $64.99 and a 52-week high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.